Medication info

Acyclovir Tablets 200 mg (Acyclovir)

Prescription medicationTabletIntravenous injectionExpired
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Jeongwoo Pharmaceutical Co., Ltd.
Appearance
Light blue round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201902823 · Approved 2019.05.01

This product's status changed to Expired on 2024.05.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of herpes simplex; treatment of shingles; treatment of chickenpox in children
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, treatment should preferably begin at the first signs or symptoms of lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal absorption disorders. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is usually not greater than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg of this drug per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg of this drug per dose 3 times daily, at approximately 8-hour intervals.
Child administration
Age 2 years or older: Same as adults. Under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children aged 2 years or older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days as this drug.

Ingredients

Manufacturer
Jeongwoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex; treatment of shingles; treatment of chickenpox in children

  • Genital herpes
  • herpes simplex virus infections of skin and mucous membranes
  • herpes zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent primary and recurrent genital herpes, as well as herpes simplex virus infections of the skin and mucous membranes. It is also effective in treating herpes zoster virus infections, particularly for the relief of acute pain. However, its efficacy for postherpetic neuralgia is still uncertain. It is also applicable for the treatment of chickenpox in children aged 2 years and older. This drug helps improve symptoms caused by viral infections across various age groups.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, treatment should preferably begin at the first signs or symptoms of lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal absorption disorders. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is usually not greater than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg of this drug per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg of this drug per dose 3 times daily, at approximately 8-hour intervals.

Child administration

Age 2 years or older: Same as adults. Under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children aged 2 years or older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days as this drug.

Precautions

This drug should not be used by patients who are allergic to this drug or its ingredients, or who have previously shown hypersensitivity to valacyclovir. Patients with impaired kidney function may be at higher risk of neuropsychiatric adverse reactions when using this drug, so caution is necessary. Patients with decreased liver function should also be cautious, as this medication may further worsen liver function. Infants and young children should be used with special caution, and should be administered the minimum dose only when necessary. Elderly patients may experience increased blood concentration of this medication due to reduced kidney function, and adverse reactions may occur more frequently; therefore, dosage and intervals should be carefully adjusted. While taking this medication, severe allergic reactions such as anaphylactic shock may rarely occur, so if symptoms such as low blood pressure, difficulty breathing, or chest tightness appear, stop using the medication immediately and inform medical personnel. Photosensitivity reactions, rashes, fever, vesicles, urticaria-like erythema may occur on the skin; if these symptoms develop, medication should be discontinued, and appropriate treatment should be initiated. Severe skin reactions including alopecia, erythema multiforme, Stevens-Johnson syndrome, or Lyell syndrome may occur, requiring careful observation of skin condition. Neuropsychiatric abnormalities such as altered consciousness, disorientation, concentration difficulties, aggression, hallucinations, seizures, drowsiness, tremors, anxiety, insomnia, may occur, particularly in the elderly and those with renal impairment. Abnormal kidney function may manifest as renal failure, hematuria, and proteinuria, so renal status should be monitored regularly. Effects on the blood and lymphatic system can lead to leukopenia, bleeding, and anemia; regular blood tests are advisable to monitor the condition. Liver function anomalies or jaundice, hepatitis symptoms may occur, so regular liver function tests are recommended. Gastrointestinal symptoms such as gastritis, nausea, vomiting, diarrhea, and abdominal pain may arise, and if these symptoms persist, inform medical personnel. Adequate hydration is necessary while using this medication, especially at high doses, to prevent dehydration and reduce the risk of nephrotoxicity. Disorientation may occur during treatment, so caution is advised when driving or operating hazardous machinery. Patients with renal impairment should be particularly careful. Interactions with other medications may occur, so it is advisable to consult a professional, particularly when used with drugs that affect renal function or probenecid, cimetidine, theophylline, mycophenolate mofetil. Pregnant women or those who may become pregnant should make careful decisions based on potential risks to the fetus while using this medication, and it is recommended to stop breastfeeding as this drug may be excreted in breast milk. In case of overdose, severe side effects such as coma, seizures, and renal failure may occur, so immediate medical attention should be sought, and blood concentration should be monitored.

Side effects

  • anaphylactic shock
  • anaphylaxis-like reaction
  • hypotension
  • dyspnea
  • chest tightness
  • phototoxic reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 117 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • excitement
  • amnesia
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • motor discoordination
  • gait dysfunction
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • increased BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function test
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • epigastric pain
  • stomachache
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorder
  • hair loss
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol levels
  • increased triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • excitement
  • epileptic seizure
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in containers that block light. Additionally, it is best to store the medication at room temperature between 1 degree Celsius and 30 degrees Celsius, to maintain its effectiveness and safety.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.